Verified factor-similar pair

VTWO vs XJH

These two ETFs meet the same FF6 US comparison criteria: US-listed equity ETFs, the same USD model basis, at least one material non-market factor, and 100% overlap in statistically significant material factor exposure.

SMB
Similarity score
81
Verified similar

The score combines exposure-level distance, factor-vector shape, market-beta closeness, and a small backtested relative-Sharpe term.

Quick Read

  • VTWO has the higher backtested relative Sharpe (0.866 vs 0.705).
  • VTWO has the lower published fee (0.06% vs 0.12%).
  • VTWO is cheaper on dividend valuation (116 vs 117, where 100 is each fund's historical median).
  • VTWO has the stronger regression fit (adjusted R-squared 0.991 vs 0.942).

These are screening signals, not a complete review of portfolio construction, turnover, taxes, or trading quality.

VTWO

Vanguard Russell 2000 ETF
SMB
Adj. R2
0.991
Rel. Sharpe
0.866
Mkt beta
1.02
AUM
US$14.8B
MER
0.06%
Valuation
116

XJH

iShares ESG Select Screened S&P Mid-Cap ETF
SMB
Adj. R2
0.942
Rel. Sharpe
0.705
Mkt beta
1.02
AUM
US$362M
MER
0.12%
Valuation
117

Factor Exposure Match

Blue bars compare raw factor beta magnitude. Green bars compare absolute t-stat strength. Dim bars indicate the t-stat is below 1.96.

SMB
VTWO
+0.85
|t|
+47.9
XJH
+0.54
|t|
+8.6
diff +0.31
HML
VTWO
+0.12
|t|
+6.8
XJH
+0.19
|t|
+3.2
diff -0.07
RMW
VTWO
-0.10
|t|
-4.8
XJH
+0.19
|t|
+2.9
diff -0.28
CMA
VTWO
-0.06
|t|
-2.2
XJH
-0.01
|t|
-0.1
diff -0.05
UMD
VTWO
+0.07
|t|
+5.2
XJH
+0.01
|t|
+0.2
diff +0.06

Why This Pair Matches

Exposure level
76
Exposure shape
94
Mkt beta diff
0.00
Rel. Sharpe diff
0.162

This comparison focuses on measured factor exposure. It does not compare holdings methodology, turnover, tax handling, or issuer process. Backtested relative Sharpe is a secondary signal rather than a stand-alone forecast. See methodology.

VTWO fund page XJH fund page US ETF Leaders US Universe
Important context

VerifiedBeta publishes educational ETF research, not personalized investment advice, portfolio management, or security recommendations. Funds that screen well here can still be unsuitable for your objectives, taxes, liquidity needs, or constraints. Review fund documents, methodology assumptions, and your own circumstances before acting. See the full disclaimer.